elon musk before and after semaglutide GLP-1 based drugs: Could Musk's weight loss weapon help us, too? Novo Nordisk's Wegovy gets a

In clinical trials, discontinuation due to gastrointestinal side effects occurred in approximately 5% of patients receiving Wegovy compared to 1% with placebo (as reported in the SmPC)

According to the FDA-approved prescribing information, patients start at 0.25 mg once weekly for the first four weeks (a dose-initiation phase not intended for blood sugar control), then increase to therapeutic doses

Leaving a pen in a hot car or close to a heat source can make it unstable in just a few hours

Global burden of 87 risk factors in 204 countries and territories, 19902019: a systematic analysis for the Global Burden of Disease Study 2019

Cardiovascular risk falls significantly